Archive · 13 Sep 2025
Modern Diagnostic Gets Approval for Upcoming IPO
Imagine a company called Modern Diagnostic that helps people by doing medical tests.
They want to raise money to grow, so they're planning to sell shares of their company to the public, which is called an IPO.
They got permission from the stock market (BSE) to start this process.
They want to use the money to buy new machines, pay their bills, and make the company better.
Modern Diagnostic has already made money, and has 21 locations across different states where they conduct tests.
They make sure their tests are accurate by checking their equipment regularly.
Modern Diagnostic & Research Centre Limited received BSE approval for an IPO.
The IPO will involve the issue of 41,00,000 fresh equity shares.
Funds raised will be used for medical equipment, working capital, debt repayment, and other expenses.
The company's revenue for FY24 was ₹6,713.05 lakhs.
Modern Diagnostic has 21 centers, including labs and diagnostic centers across eight states.
- Who
- Modern Diagnostic & Research Centre Limited
- What
- Received approval from BSE to file for an initial public offering (IPO).
- When
- The company informed on Friday, September 12, about BSE's approval.
- Where
- Across 8 states.
- Why
- To raise funds for medical equipment, working capital, debt repayment, and other expenses.
- Company Name
- Modern Diagnostic & Research Centre Limited
- IPO Type
- SME IPO
- BSE Approval Date
- September 12
- Fresh Equity Shares
- 41,00,000
- Face Value of Shares
- ₹10 each
- Book-Running Lead Manager
- Beeline Capital Advisors Private Limited
- Registrar
- MUFG Intime India Private Limited
- FY24 Revenue
- ₹6,713.05 lakhs
- FY24 Net Profit
- ₹579.48 lakhs
- Number of Centers
- 21 (17 labs, 4 diagnostic centres)